Effective July 1, 2024, Joseph A. Staples was appointed to the Board of the Company to serve for a term expiring at the earlier of the Company’s next annual meeting of stockholders or his resignation or appointment of a duly elected successor.
On June 30, 2024, Stephanie Bowers resigned as a member of the board of directors (the “Board”) of the Company, including from her position on the Nominating and Corporate Governance Committee, effective immediately.
filled a vacant Board seat by appointing Dion Hinchcliffe to serve as a member of the Board of Directors effective as of the close of business on July 1, 2024
On June 27, 2024, Joshua Tamaroff resigned from the Board of Directors (the “Board”) and Audit Committee of the Board (the “Audit Committee”) of OmniAb, Inc. (the “Company”), effective June 28, 2024, due to his pending departure from Avista Capital Partners.
Departed
Vickie S. Reed
Director
DMK PHARMACEUTICALS Corp
Effective
2024-06-27
Filed
July 1, 2024, 7:59 PM ET
Additionally, Howard C. Birndorf, Meera J. Desai, Ph.D, NACD.DC, Vickie S. Reed, and Jannine C. A. Versi resigned as Directors of the Company.
Departed
Jannine C. A. Versi
Director
DMK PHARMACEUTICALS Corp
Effective
2024-06-27
Filed
July 1, 2024, 7:59 PM ET
Additionally, Howard C. Birndorf, Meera J. Desai, Ph.D, NACD.DC, Vickie S. Reed, and Jannine C. A. Versi resigned as Directors of the Company.
Departed
Meera J. Desai
Director
DMK PHARMACEUTICALS Corp
Effective
2024-06-27
Filed
July 1, 2024, 7:59 PM ET
Additionally, Howard C. Birndorf, Meera J. Desai, Ph.D, NACD.DC, Vickie S. Reed, and Jannine C. A. Versi resigned as Directors of the Company.
Departed
Howard C. Birndorf
Director
DMK PHARMACEUTICALS Corp
Effective
2024-06-27
Filed
July 1, 2024, 7:59 PM ET
Additionally, Howard C. Birndorf, Meera J. Desai, Ph.D, NACD.DC, Vickie S. Reed, and Jannine C. A. Versi resigned as Directors of the Company.
On June 26, 2024, Janet L. Miller submitted her resignation, effective as of June 28, 2024, as a member of the Board of Directors of Cleveland-Cliffs Inc.
On June 27, 2024, the Board of Directors (the “Board”) of Bitcoin Depot Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Ms. Teri G. Fontenot to the Board, effective July 1, 2024, to fill the vacancy on the Board caused by the resignation of Jackie Marks.
Departed
Eric Rahe
director
Vericity, Inc.
Filed
June 28, 2024, 7:59 PM ET
each of the seven directors of the Company prior to consummation of the Merger (Eric Rahe, Richard A. Hemmings, James E. Hohmann, Neil Ashe, Calvin Dong, Scott Perry and Laura R. Zimmerman) ceased to be directors of the Company.
Appointed
Sean O'Brien
director
Vericity, Inc.
Filed
June 28, 2024, 7:59 PM ET
the directors of Merger Sub in office immediately prior to consummation of the Merger (Denis Ricard, Michael L. Stickney, Joe W. Dunlap, Sean O'Brien and James E. Hohmann) became the directors of the Company at the Effective Time
Departed
Richard A. Hemmings
director
Vericity, Inc.
Filed
June 28, 2024, 7:59 PM ET
each of the seven directors of the Company prior to consummation of the Merger (Eric Rahe, Richard A. Hemmings, James E. Hohmann, Neil Ashe, Calvin Dong, Scott Perry and Laura R. Zimmerman) ceased to be directors of the Company.
Appointed
James E. Hohmann
director
Vericity, Inc.
Filed
June 28, 2024, 7:59 PM ET
the directors of Merger Sub in office immediately prior to consummation of the Merger (Denis Ricard, Michael L. Stickney, Joe W. Dunlap, Sean O'Brien and James E. Hohmann) became the directors of the Company at the Effective Time
Appointed
Joe W. Dunlap
director
Vericity, Inc.
Filed
June 28, 2024, 7:59 PM ET
the directors of Merger Sub in office immediately prior to consummation of the Merger (Denis Ricard, Michael L. Stickney, Joe W. Dunlap, Sean O'Brien and James E. Hohmann) became the directors of the Company at the Effective Time
Departed
James E. Hohmann
director
Vericity, Inc.
Filed
June 28, 2024, 7:59 PM ET
each of the seven directors of the Company prior to consummation of the Merger (Eric Rahe, Richard A. Hemmings, James E. Hohmann, Neil Ashe, Calvin Dong, Scott Perry and Laura R. Zimmerman) ceased to be directors of the Company.
Appointed
Michael L. Stickney
director
Vericity, Inc.
Filed
June 28, 2024, 7:59 PM ET
the directors of Merger Sub in office immediately prior to consummation of the Merger (Denis Ricard, Michael L. Stickney, Joe W. Dunlap, Sean O'Brien and James E. Hohmann) became the directors of the Company at the Effective Time
Departed
Laura R. Zimmerman
director
Vericity, Inc.
Filed
June 28, 2024, 7:59 PM ET
each of the seven directors of the Company prior to consummation of the Merger (Eric Rahe, Richard A. Hemmings, James E. Hohmann, Neil Ashe, Calvin Dong, Scott Perry and Laura R. Zimmerman) ceased to be directors of the Company.
Appointed
Denis Ricard
director
Vericity, Inc.
Filed
June 28, 2024, 7:59 PM ET
the directors of Merger Sub in office immediately prior to consummation of the Merger (Denis Ricard, Michael L. Stickney, Joe W. Dunlap, Sean O'Brien and James E. Hohmann) became the directors of the Company at the Effective Time
Departed
Calvin Dong
director
Vericity, Inc.
Filed
June 28, 2024, 7:59 PM ET
each of the seven directors of the Company prior to consummation of the Merger (Eric Rahe, Richard A. Hemmings, James E. Hohmann, Neil Ashe, Calvin Dong, Scott Perry and Laura R. Zimmerman) ceased to be directors of the Company.
Departed
Neil Ashe
director
Vericity, Inc.
Filed
June 28, 2024, 7:59 PM ET
each of the seven directors of the Company prior to consummation of the Merger (Eric Rahe, Richard A. Hemmings, James E. Hohmann, Neil Ashe, Calvin Dong, Scott Perry and Laura R. Zimmerman) ceased to be directors of the Company.
Departed
Scott Perry
director
Vericity, Inc.
Filed
June 28, 2024, 7:59 PM ET
each of the seven directors of the Company prior to consummation of the Merger (Eric Rahe, Richard A. Hemmings, James E. Hohmann, Neil Ashe, Calvin Dong, Scott Perry and Laura R. Zimmerman) ceased to be directors of the Company.
On June 25, 2024, in connection with the IPO, Louis Bélanger-Martin, Kenneth Weinstein and Fred Zeidman were appointed to the board of directors of the Company.
On June 25, 2024, in connection with the IPO, Louis Bélanger-Martin, Kenneth Weinstein and Fred Zeidman were appointed to the board of directors of the Company.
On June 25, 2024, in connection with the IPO, Louis Bélanger-Martin, Kenneth Weinstein and Fred Zeidman were appointed to the board of directors of the Company.
Appointed
Jodie Morrison
Director
Verve Therapeutics, Inc.
Effective
2024-06-26
Filed
June 28, 2024, 7:59 PM ET
elected, effective immediately, Jodie Morrison as a member of the Board
Appointed
Ourania "Nia" Tatsis, Ph.D.
Director
Verve Therapeutics, Inc.
Effective
2024-06-26
Filed
June 28, 2024, 7:59 PM ET
Ourania "Nia" Tatsis, Ph.D. as a member of the Board
Appointed
Susan Roth Katzke
Director
Blackstone Private Equity Strategies Fund L.P.
Effective
2024-06-27
Filed
June 28, 2024, 7:59 PM ET
On June 27, 2024, the General Partner and the Fund’s board of directors (the “Board”) appointed Susan Roth Katzke to the Board as an independent director.
Departed
Timothy Eriksen
director
TSR INC
Effective
2024-06-28
Filed
June 28, 2024, 7:59 PM ET
As of the Effective Time, Robert Fitzgerald, Timothy Eriksen and Bradley Tirpak each ceased to be directors of the Company and members of any committee of the Company’s board of directors.
Departed
Robert Fitzgerald
director
TSR INC
Effective
2024-06-28
Filed
June 28, 2024, 7:59 PM ET
As of the Effective Time, Robert Fitzgerald, Timothy Eriksen and Bradley Tirpak each ceased to be directors of the Company and members of any committee of the Company’s board of directors.
Departed
Bradley Tirpak
director
TSR INC
Effective
2024-06-28
Filed
June 28, 2024, 7:59 PM ET
As of the Effective Time, Robert Fitzgerald, Timothy Eriksen and Bradley Tirpak each ceased to be directors of the Company and members of any committee of the Company’s board of directors.
Appointed
Justin Christian
director
TSR INC
Effective
2024-06-28
Filed
June 28, 2024, 7:59 PM ET
The sole director of Merger Sub immediately prior to the Effective Time was Justin Christian.
Departed
Mark Bonyhadi
Director
TC BioPharm (Holdings) plc
Effective
2024-06-26
Filed
June 28, 2024, 7:59 PM ET
On June 26, 2024, each of Mark Bonyhadi and Edward Niemzyck submitted his respective resignation to the board of directors of TC Biopharm (Holdings) PLC (the “Company”), effective immediately.
Departed
Edward Niemzyck
Director
TC BioPharm (Holdings) plc
Effective
2024-06-26
Filed
June 28, 2024, 7:59 PM ET
On June 26, 2024, each of Mark Bonyhadi and Edward Niemzyck submitted his respective resignation to the board of directors of TC Biopharm (Holdings) PLC (the “Company”), effective immediately.
On June 26, 2024, James P. Geiskopf, a member of the Board of Directors of MetaWorks Platforms, Inc. and Chairman of the Audit Committee thereof, notified the Company of his intention to resign from the Company’s Board of Directors, effective June 28, 2024.
On June 26, 2024, Gurminder Bedi, a Class I director of Blue Bird Corporation (the “Company”), informed our Chairman of the Board that he was resigning from our Board of Directors, effective immediately.
On June 25, 2024, the Board of Directors (the “Board”) of PayPal Holdings, Inc. (the “Company”) appointed Carmine Di Sibio as a new member of the Company’s Board, effective July 1, 2024.
Effective June 28, 2024, the Board, upon the recommendation of its Nominating and Governance Committee, appointed Ms. Maria Ross as a member of the Board.
On June 25, 2024, Dr. Hong Wang informed the Board of Directors (the “Board”) of HF Foods Group Inc. (the “Company”) of his intention to resign from the Board and all committees thereof, effective June 28, 2024.
Appointed
Patrick McNamee
director
LUXURBAN HOTELS INC.
Effective
2024-06-27
Filed
June 28, 2024, 7:59 PM ET
Effective June 27, 2024, Patrick McNamee joined our board of directors and will also serve on the board’s compensation committee, as its chairman, and on the board’s nominating committee.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.